OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GKOS

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Glaukos (GKOS) Earnings Date & Reports

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

GKOS is expected to report earnings to rise 3.38% to -24 cents per share on October 29

Q3'25

Est.

$-0.25

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.13

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.20

The last earnings report on July 30 showed earnings per share of -23 cents, beating the estimate of -25 cents. With 219.88K shares outstanding, the current market capitalization sits at 4.85B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

GKOS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GKOS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GKOS showed earnings on July 30, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

an ophthalmic medical device company

Industry MedicalNursingServices

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

One Glaukos Way

Phone

+1 949 367-9600

Employees

907

Web

https://www.glaukos.com